Shi Si Yao Group: Drugs such as low-calcium peritoneal dialysis fluid have obtained production registration approval
2026-11-19 13:00:20
According to CoinMeta, Shisiyao Group (02005.hk) has issued a announcement stating that it has obtained the drug production registration approvals from the China National Medical Products Administration for low-calcium peritoneal dialysis fluid (bicarbonate g1.5%), peritoneal dialysis fluid (bicarbonate- g2.5%), peritoneal dialysis fluid (bicarbonate- g4.25%), and low-calcium peritoneal dialysis fluid (bicarbonate- g4.25%). These products are all available in a 2000ml specification and fall under Class 3 of chemical drugs, and are considered to have passed the consistency evaluation. Among them, the low-calcium peritoneal dialysis fluid (bicarbonate- g4.25%) is the third product of its kind approved by a domestic company. These products are mainly used for peritoneal dialysis in patients with chronic renal failure and are used when hypermagnesemia has not been adequately improved.
Bullish 0
Bearish 0
Source:Jin10 Data
This content is for market information only and does not constitute investment advice.